PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
17-Aug-2021 Stevanato Group Announces Underwriters’ Partial Exercise of Over-Allotment Option Businesswire
17-Aug-2021 $4.3 Bn NLP in Healthcare and Life Sciences (Rule-based, Statistical, and Hybrid) Markets - Global Forecast to 2026 - ResearchAndMarkets.com Businesswire
17-Aug-2021 Procaps Group Appoints Patricio Vargas as Global Chief Financial Officer to Support Global Expansion Businesswire
17-Aug-2021 Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results Businesswire
17-Aug-2021 n-Lorem Foundation Appoints Sarah Glass, Ph.D., as Chief Development Officer Businesswire
17-Aug-2021 PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments Businesswire
17-Aug-2021 Istari Oncology Initiates Its Phase I/II Sub-Study Evaluating PVSRIPO in Patients with Head and Neck Cancer Businesswire
17-Aug-2021 23.6 Bn Silicone (Elastomers, Fluids, Resins, Gels) Markets - Global Forecast to 2026 - ResearchAndMarkets.com Businesswire
17-Aug-2021 Alzamend Neuro Announces It Has Contracted With Altasciences to Conduct a Phase I Relative Bioavailability Study for AL001 for Dementia Related to Alzheimer’s Disease in September 2021 Businesswire
17-Aug-2021 Tenax Therapeutics Reports Second Quarter 2021 Results and Provides Business Update Businesswire
17-Aug-2021 Sparrow Pharmaceuticals Expands Executive Leadership With Appointment of Frank Czerwiec, MD as Chief Medical Officer and Jamie MacPherson, PharmD as Vice President of Regulatory Affairs and Quality Businesswire
17-Aug-2021 CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines Businesswire
17-Aug-2021 Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments Businesswire
17-Aug-2021 Xellia Pharmaceuticals Cleveland, Ohio Manufacturing Facility Commercially Operational for Production of Key Anti-Infective Drug Products for US Hospitals and Patients Businesswire
17-Aug-2021 Receptor Life Sciences Announces Publication of Proof-of-Principle Clinical Pharmacokinetics Study of RLS103 (Inhaled Dry Powder CBD) Businesswire
17-Aug-2021 Global $46.33 Bn Plant Extracts Markets to 2028 - Focus on Phytomedicines & Herbal Extracts, Essential Oils, Spices, Flavors & Fragrances - ResearchAndMarkets.com Businesswire
17-Aug-2021 The IMA Group Announces Acquisition of MedPlus Disability Evaluations Businesswire
17-Aug-2021 $300+ Bn Contract Development and Manufacturing Organization (CDMO) Markets - Global Analysis & Forecast Report 2021-2026 - ResearchAndMarkets.com Businesswire
17-Aug-2021 Papyrus Therapeutics Inc. Announces Additions to Its Board of Directors Businesswire
17-Aug-2021 Antibe Therapeutics Reports Q1 2022 Interim Financial and Operating Results Businesswire